D
DeepPsy
Switzerland · Healthtech
DeepPsy analyses EEG and ECG recordings to give psychiatrists biomarker reports that support treatment selection for depression.
Product
DeepPsy develops biomarker reports from measurements of brain and heart activity. Psychiatrists use the reports as additional information when selecting treatments for depression, including medicines and brain-stimulation approaches.
Based in Zollikon, Switzerland, the company is working to expand clinical adoption and strengthen evidence for its approach. Its software turns EEG and ECG data into a report for treatment discussions.
Funding history
2 rounds · 0 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Future of Health Grant Level 3 | Undisclosed | Future of Health Grant — Participant | |
| Future of Health Grant Level 2 | Undisclosed | Future of Health Grant — Participant |